Stockreport

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF TEL AVIV, Israel, Aug. 7, 2018  /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced today the Eu [Read more]